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Somatic stem cells are present in most tissues of 
the adult body. They control the continuous 
production of differentiated cell types in highly 
regenerative tissues such as the gastrointestinal 
mucosa, skin epidermis, and blood. They also 
play a critical role in response to tissue injury, 
during which they become actively engaged in 
repair processes. The self-renewal and differ-
entiation activity of stem cells is controlled by 
their  surrounding  microenvironment,  which 
is known as the stem cell niche. Although the 
concept of niches is well accepted and experi-
mentally proven in various invertebrate systems, 
mammalian stem cell niches remain poorly   
understood, as the precise location of the stem 
cells themselves often remains elusive. One of 
the most well-characterized somatic stem cells 
in mammals is the mouse hematopoietic stem 
cell (HSC), which resides in the bone marrow. 
Using  multiparameter  flow  cytometry,  lin-
negSca1hic-Kit+CD34CD48CD150hi  HSCs 
can be identified and isolated prospectively. At 
the clonal level, these cells can reconstitute the 
entire hematopoietic system of lethally irradi-
ated mice and are serially transplantable (Purton 
and Scadden, 2007; Wilson et al., 2007). Be-
cause HSCs are preferentially found as single 
cells in the trabecular cavities of long bones, 
their niche location is assumed to be nearby. 
However, there is significant debate about the 
more  detailed  location  of  HSCs  within  this 
area,  which  contains  not  only  the  endosteal 
region, located in the immediate proximity of 
the bone lining osteoblasts (OBs), but also a 
highly vascularized area toward the center of 
the bone marrow (Fig. 1). Several studies have 
attempted to localize HSCs in bone sections or 
by using confocal/two-photon intravital imag-
ing based on three-color fluorescence micros-
copy (Lord and Hendry, 1972; Nilsson et al., 
2001; Lo Celso et al., 2009; Xie et al., 2009). 
However, these techniques do not define resi-
dent HSCs as accurately as eight-parameter flow 
cytometry, admitting the possibility that early 
progenitors rather than bona fide HSCs were 
imaged. Nevertheless, putative HSCs have been 
found near the endosteum lined by OBs (end-
osteal niche) or in association with sinusoidal   
endothelium (perivascular niche; Fig. 1 and 
Fig. 2). Importantly, sinusoids are also found 
close to the endosteum, but are more abundant 
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Stem cell niches are defined as the cellular and molecular microenvironments that 
regulate stem cell function together with stem cell autonomous mechanisms. This 
includes control of the balance between quiescence, self-renewal, and differentiation, 
as well as the engagement of specific programs in response to stress. In mammals, the 
best understood niche is that harboring bone marrow hematopoietic stem cells (HSCs). 
Recent studies have expanded the number of cell types contributing to the HSC niche. 
Perivascular mesenchymal stem cells and macrophages now join the previously identi-
fied sinusoidal endothelial cells, sympathetic nerve fibers, and cells of the osteoblastic 
lineage to form similar, but distinct, niches that harbor dormant and self-renewing 
HSCs during homeostasis and mediate stem cell mobilization in response to granulocyte 
colony-stimulating factor.
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MSCs by inducible expression of diph-
theria toxin receptor (DTR) in nestin-
expressing cells caused the mobilization 
of 50% of HSCs to the spleen. In 
addition, the homing of transplanted 
progenitor cells into MSC-depleted 
recipients was reduced by 90%.
Moreover,  treatment  with  the  HSC-mobilizing  factor 
granulocyte colony-stimulating factor (G-CSF) decreased the 
expression of CXCL12 and other factors required for HSC 
maintenance and retention by nestin+ MSCs. These cells also 
seem to mediate the capacity of parathyroid hormone to in-
crease HSC numbers, which had previously been correlated 
with an increase in putative niche OBs (Calvi et al., 2003; 
Adams et al., 2007). Parathyroid hormone directly stimulated 
proliferation of nestin+ MSCs while simultaneously promot-
ing  their  differentiation  into  OBs  (Méndez-Ferrer  et  al., 
2010). Collectively, these data support the hypothesis that 
nestin+ MSCs are a functional component of the bone mar-
row HSC niche.
Most interestingly, nestin+ MSCs show several similarities 
to recently identified mesenchymal progenitors (Sugiyama   
et al., 2006; Omatsu et al., 2010). These bipotent adipoosteo-
genic progenitors were identified in a mouse strain in which 
GFP was expressed from the endogenous CXCL12 locus 
(Sugiyama et al., 2006; Omatsu et al., 2010). Because of their 
high CXCL12 expression and their long cellular processes, 
these cells were named CXCL12-abundant reticular (CAR) 
cells. The majority of putative HSCs are found in close prox-
imity to CAR cells by immunohistochemistry, and like nes-
tin+ MSCs, CAR cells are predominantly found in the more 
central areas of the marrow, with some also located close to 
vessels near the endosteum (Fig. 1). Although CAR cells are 
more abundant than nestin+ MSCs, they too are tightly asso-
ciated with sinusoidal endothelium and have a similar mor-
phology to vascular pericytes. These data are in agreement 
with studies in humans, suggesting that virtually all MSC ac-
tivity is found within the larger pericyte population that 
associates closely with the vascular system in the entire body 
(Crisan et al., 2008).
Similar to nestin+ MSCs, CAR cells express HSC main-
tenance proteins such as CXCL12 and SCF. Induced deple-
tion of CAR cells using a DTR approach causes a partial loss 
of HSC activity associated with a decrease in HSC cycling, 
at  greater  distances  from  the  bone  surfaces  (Wilson  and 
Trumpp, 2006; Kiel and Morrison, 2008). Thus, the iden-
tity and composition of the niche housing functional HSCs 
remains unclear.
It is also possible that there is more than one niche, and 
that HSCs are not static, but instead dynamically change their 
niche location in response to injury or to feedback signals 
(Trumpp et al., 2010). Directly relating to this point, it must 
be noted that several of the studies designed to identify the lo-
cation of the HSC niche make use of mice that have received 
total body irradiation. Under these conditions, it is highly 
likely that the niche is undergoing a dynamic remodeling pro-
cess and may not be identical to the homeostatic HSC niche. 
Moreover, the location of some important cellular compo-
nents of the niches may not be restricted to the endosteum or 
the perivascular niche area, but may be part of both environ-
ments, raising the possibility that both niches and the location 
of HSCs may not be as distinct as is currently assumed.
Mesenchymal stem cells (MSCs): the main niche players
Support for the hypothesis that one cell type is present at var-
ious sites within the marrow niche was obtained by a recent 
landmark study by Méndez-Ferrer et al. (2010). This group 
identified a stromal nestin-expressing MSC population (nes-
tin+ MSC) that is closely associated with putative HSCs.   
Nestin+ MSCs are strictly perivascular and are typically found 
in more central areas of the marrow, but they are also present 
in the immediate vicinity of the endosteum, albeit at lower 
frequency. Moreover, nestin+ MSCs are tightly associated 
with adrenergic nerve fibers of the sympathetic nervous sys-
tem (SNS) that regulate HSC mobilization and are responsi-
ble for the circadian oscillations in circulating HSC numbers 
(Katayama et al., 2006; Méndez-Ferrer et al., 2008). Strik-
ingly, these MSCs express higher levels of HSC maintenance 
factor transcripts, including CXCL12, stem cell factor (SCF), 
angiopoietin-1 (Ang-1), IL-7, vascular cell adhesion mole-
cule 1 (VCAM1), and osteopontin (OPN), compared with any 
other stromal cell type including OBs. Depletion of nestin+ 
Figure 1.  Location of HSC niches in tra-
becular bone cavities. HSCs are located at 
the endosteum, which is lined by OBs and is 
remodeled by osteoclasts. OBs promote HSC 
maintenance. Vascular sinusoids are found 
close to the endosteum, but more frequently 
at greater distances. HSCs are also situated 
nearby sinusoids toward the center of the 
marrow. Perivascular nestin+ MSCs and the 
more abundant CAR cells promote HSC 
maintenance.JEM VOL. 208, March 14, 2011  423
Review
two-photon  intravital  imaging  (Lord  and  Hendry,  1972; 
Nilsson et al., 2001; Calvi et al., 2003; Zhang et al., 2003). 
HSCs isolated from endosteal regions by FACS show higher 
reconstitution activity compared with phenotypically identi-
cal cells from the center of the bone marrow (Grassinger   
et al., 2010).
The cell type initially suggested to be critical within the 
so-called endosteal niche was the bone-lining, spindle-shaped 
OB, which displays a CD45CD31TER119Sca1CD51+ 
phenotype. Induced depletion of OBs causes mobilization of 
HSCs/progenitors to the spleen, and some genetically modi-
fied mice with augmented OBs show a simultaneous increase 
in HSC numbers (Calvi et al., 2003; Zhang et al., 2003; Visnjic 
et al., 2004; Zhu et al., 2007). Furthermore, a population of 
CD45CD105+ osteoprogenitor cells from fetal long bone 
or calvaria is sufficient to generate an HSC niche when trans-
planted under the kidney capsule (Chan et al., 2009). Simi-
larly, adult human bone marrow contains a population of 
self-renewing CD45CD146+ perivascular osteoprogenitors 
that can generate bone and marrow when transplanted under 
the skin of immunodeficient mice (Sacchetti et al., 2007). 
Moreover, HSCs express the calcium ion receptor, which 
has been demonstrated to be important for HSC engraftment 
at the endosteum by enabling HSCs to follow the Ca2+ gra-
dient that results from bone remodeling processes occurring 
at the endosteum (Adams et al., 2006). Finally, OBs produce 
suggesting that CAR cells promote HSC cycling and self-
renewal. Even though this phenomenon was not observed 
after depletion of nestin+ MSCs, it seems likely that CAR 
cells and nestin+ MSCs represent two highly overlapping 
CXCL12-expressing cell populations. Because nestin+ MSCs 
are approximately four times less abundant than CAR cells, 
contain all colony-forming-unit fibroblast activity within 
the marrow, harbor high self-renewal activity in vitro and 
in vivo, and are capable of multilineage differentiation into 
bone, cartilage, and fat, it appears that nestin+ MSCs may 
represent a more primitive population compared with CAR 
cells and may even be a CAR subpopulation. As it remains 
unclear whether nestin+ MSCs are homogeneous and whether 
they all express high levels of CXCL12, it is possible that 
some nestin+ MSCs may not be CAR cells. Although future 
studies will need to dissect the cellular relationship between 
these two niche cell populations, there is now convincing 
evidence that perivascular mesenchymal stem/progenitor cells 
are critical inhabitants of the HSC niche.
OBs and the endosteal niche
Nestin+ MSCs and CAR cells are able to generate osteopro-
genitor intermediates and, eventually, OBs, which line the 
bone surface at the endosteum. This was the first location to 
be proposed as the putative HSC niche, and HSCs at the 
endosteum have subsequently been identified by confocal/
Figure 2.  Model illustrating the quiescent endosteal and the active perivascular HSC niche during bone marrow homeostasis. Deeply quies-
cent (dormant) HSCs in the endosteal niche are likely in close contact with OBs and nestin+ MSCs, both of which supply HSC maintenance and quiescence 
factors, including CXCL12, SCF, Ang-1, VCAM-1, and TPO, and cooperate to retain HSCs in their niche. MSCs can generate OBs, adipocytes, and chondro-
cytes. The perivascular niche is more distant from the endosteum and does not contain OBs, but includes perivascular CAR cells that secrete factors that 
promote self-renewal of active HSCs, which are significantly more abundant than dormant HSCs. Self-renewal is also stimulated by Notch ligands ex-
pressed by sinusoidal endothelial cells. Both niches contain perivascular nestin+ MSCs as a key component. Different subtypes of phagocytes support the 
maintenance of OBs (osteomacs) and maintenance and proliferation of MSCs (macrophages). They also induce the expression of HSC maintenance fac-
tors. The SNS inhibits MSC proliferation and induces circadian oscillations of CXCL12 expression. CAMS, cell adhesion molecules.424 New players join the HSC niche | Ehninger and Trumpp
concept, several groups have identified long-term quiescent, 
so-called dormant HSCs in the healthy adult bone marrow. 
These cells harbor the highest self-renewal capacity among all 
blood progenitors and, although typically dormant during 
homeostasis, they can be induced to reenter the cell cycle in 
response to cytokines like type I or II IFN, G-CSF, or injury 
signals such as those generated by chemotherapy-induced 
myelosuppression (Wilson et al., 2008; Essers et al., 2009; 
Foudi et al., 2009; Schaniel and Moore, 2009; Baldridge et al., 
2010; Trumpp et al., 2010; Takizawa et al., 2011). Thus, we 
postulate the existence of two highly similar niches, one har-
boring dormant HSCs and one housing self-renewing HSCs 
(Fig. 2; Trumpp et al., 2010). Both niches may rely on peri-
vascular MSCs, but the endosteal niche could maintain a 
small dormant HSC population via the additional presence of 
TPO-producing OBs embedded in a calcium-rich micro-
environment. Because CAR cells promote HSC self-renewing 
division, they are likely only part of the perivascular niche. In 
the remainder of this review, we will use this model as a basis 
to integrate recent studies demonstrating that monocytes/
macrophages are another niche cell type that is critical for 
HSC maintenance during homeostasis and G-CSF–induced 
HSC mobilization.
Macrophages join the niche
Bone marrow niches are highly complex, and three recent 
studies (including Chow et al. and Christopher et al. in the 
previous issue of the JEM) add to this complexity by report-
ing a role for bone marrow mononuclear phagocytes in pro-
moting maintenance and retention of HSCs (Winkler et al., 
2010). First, Chow et al. (2011) developed a strategy to 
subdivide neutrophils, Gr-1hi and Gr-1lo monocytes, and 
Gr1F4/80+CD169+ macrophages. Next, they used four dif-
ferent models to deplete various overlapping monocyte/
macrophage populations from mouse bone marrow. These 
included clodronate-loaded liposomes, an inducible c-fms 
promoter-driven Fas-mediated cell depletion mouse model 
(macrophage  Fas-induced  apoptosis  [MAFIA]),  and  trans-
genic animals in which the DTR is driven by Gr-1 or CD169. 
In all cases, loss of monocytes and/or macrophages was asso-
ciated with mobilization of HSCs out of the bone marrow 
into the peripheral blood and spleen (Fig. 3). This was associ-
ated with a 40% reduction in CXCL12 protein in the bone 
marrow extracellular fluid. Because CXCL12-mediated acti-
vation of the CXCR4 receptor on HSCs is a critical niche 
retention signal (Lapidot and Petit, 2002; Broxmeyer, 2008), 
these data provide a plausible explanation for the phenotype 
observed in these mice. Mobilization was similar in all deple-
tion models. Thus, as the CD169-driven DTR model was 
the most restricted, the loss of CD169+ macrophages rather 
than monocytes appears to be critical for the mobilization of 
HSCs (Chow et al., 2011).
To further address the mechanism of this striking mobili-
zation effect, the authors isolated nestin+ MSCs and OBs 
from clodronate-treated and control mice and examined the 
expression of HSC maintenance factors in the presence or 
factors that are known to be involved in HSC retention and 
maintenance, including CXCL12, OPN, and N-cadherin, in 
addition to factors that keep HSCs in a quiescent state, including 
Ang-1, membrane-bound SCF, and thrombopoietin (TPO; Arai 
et al., 2004; Yoshihara et al., 2007; Thoren et al., 2008).
The identification of perivascular MSC/CAR cells as key 
niche cells now calls into question the role of OBs as HSC 
niche components, as MSCs generate OBs that remain in the 
close vicinity but may not contribute directly to the niche 
activity. Accordingly, a recent study suggests that osterix+ 
osteoprogenitors rather than mature osteocalcin+ OBs are 
required for the integrity of the niche (Raaijmakers et al., 
2010). In addition, MSCs seem to express much higher levels 
of some HSC maintenance factors compared with OBs 
(CXCL12, SCF, IL-7, VCAM1, and OPN; Méndez-Ferrer 
et al., 2010). However, to what degree the expression levels 
of these factors influence niche activity remains unclear. 
Importantly, sinusoidal endothelium with associated MSC/
CAR cells is also found directly at the endosteum. This raises 
the possibility that endosteal HSCs, although being close to 
OBs, are still part of a perivascular niche with OBs playing no 
direct role in HSC function. Conversely, some bone marrow 
HSCs localized far away from bone surfaces might simply 
have been caught in histological sections during migration 
from a niche to a vessel (Wright et al., 2001). Moreover, 
mobilized HSCs present at extramedullary sites like the spleen 
have no contact with osteoblastic cells, although whether the 
splenic environment maintains HSC self-renewal as well as 
the bone marrow remains questionable.
Although it has been suggested that the endosteum is not 
important for HSC function, it may be too early to dismiss 
OBs as critical niche components (Kiel et al., 2005; Méndez-
Ferrer et al., 2010). OBs express several factors important for 
HSC function, including membrane-bound SCF, and they 
seem to be the exclusive source of TPO (Arai et al., 2009). 
Importantly, TPO signaling via the c-MPL receptor has 
been shown to mediate HSC quiescence (Qian et al., 2007; 
Yoshihara et al., 2007), which is a typical feature of the most 
potent HSCs in steady-state bone marrow (Wilson et al., 
2008). Moreover, although c-MPL/ mice are born with 
normal numbers of HSCs, their frequency progressively de-
clines with age, demonstrating a critical role for OB-derived 
TPO in adult HSC maintenance in vivo (Qian et al., 2007; 
Yoshihara et al., 2007).
How  can  the  two  aforementioned  niche  concepts  be 
combined to form a comprehensive picture of HSC niches? 
Although various putative niche cell types have been experi-
mentally ablated using the DTR or thymidine kinase systems, 
in none of these experiments (MSC, CAR, or OB) did 
HSCs disappear completely or become mobilized as a whole 
(Visnjic et al., 2004; Zhu et al., 2007; Méndez-Ferrer et al., 
2010; Omatsu et al., 2010). This suggests either that the de-
pletion systems are inefficient or that there is some redun-
dancy in the system (or both). It further raises the possibility 
that more than one niche environment exists, and the distinct 
niches may house different subtypes of HSCs. In favor of this JEM VOL. 208, March 14, 2011  425
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bone surface lined with OBs and the amount of newly formed 
bone matrix decreased. The loss of OBs was independently 
confirmed by the decrease of osteocalcin expression in the 
bone  marrow.  The  latter  data  conflict  with  the  study  by 
Chow et al. (2011), who did not observe reduced OB num-
bers or decreased OB expression of HSC maintenance factors 
when phagocytes were depleted. Although this issue has yet 
to be resolved, the data from both studies suggest that phago-
cytes, potentially of different types, are likely to form part of 
both niches (Fig. 2) and are positive regulators of perivascular 
MSCs and endosteal OBs.
G-CSF induces HSC mobilization by targeting monocytes
The recent studies also addressed the mechanism of G-CSF–
induced  mobilization  of  HSCs  into  the  peripheral  blood 
(Winkler et al., 2010; Chow et al., 2011; Christopher et al., 
2011). This method has been used for many years to harvest 
functional HSCs for stem cell transplantation (Gertz, 2010), 
but the cellular and molecular mechanisms for this striking 
indirect effect (HSCs do not express G-CSF receptor) remain 
poorly understood. Christopher et al. (2011) show that G-CSF 
receptor expression on cells of the monocytic lineage is suffi-
cient for G-CSF–induced mobilization of HSCs (Fig. 3). By 
generating mice expressing G-CSFR exclusively on CD68+ 
monocytic cells, they show that HSC mobilization in these 
mice was restored compared with mice lacking the recep-
tor, suggesting that activation of the G-CSFR in mono-
nuclear phagocytes is sufficient to mediate HSPC mobilization. 
absence of mononuclear phagocytes. Although the expres-
sion of CXCL12, SCF, Ang-1, and VCAM1 mRNAs were 
strongly reduced in nestin+ MSCs in the absence of phago-
cytes, they were unchanged in sorted OBs. Phagocyte deple-
tion did not reduce the numbers of either cell population. 
These data suggest that macrophages are positive regulators of 
the nestin+ MSC niche cells that are required to maintain ex-
pression of various HSC retention factors, including CXCL12. 
But how do macrophages talk to MSCs? Although the au-
thors provide data suggesting that this effect is mediated by a 
protein secreted by macrophages, and they rule out a role for 
IGF-1, IL-1, TNF, and IL-10, the candidate factors remain 
elusive. Thus, the identification of the proteins that mediate 
the positive interaction between CD169+ macrophages and 
nestin+ MSCs remains a key issue for future studies.
A critical role for monocytes/macrophages was also sug-
gested by Winkler et al. (2010). After phagocyte depletion 
using clodronate liposomes or the MAFIA model, they also 
observed mobilization of functional HSCs with repopulating 
activity. This phenotype was associated with a decrease in 
transcripts of CXCL12, Ang-1, and SCF in total bone mar-
row and in endosteal stroma, which likely contains OBs and 
MSCs. Most strikingly, clodronate depletion was associated 
with the loss of F4/80+ macrophages specifically associated 
with the endosteal lining, which have previously been char-
acterized as osteomacs (Chang et al., 2008; Winkler et al., 
2010). The loss of phagocytes caused a significant decrease in 
osteoblastic activity at the bone surface, as the proportion of 
Figure 3.  Model illustrating the quiescent endosteal niche and the active perivascular HSC niche after stimulation with G-CSF or depletion 
of monocytes/macrophages. Upon stimulation with G-CSF, which binds G-CSFR on monocytic cells, the monocytes/macrophages disappear. As a conse-
quence of their missing supportive activity, OB activity is decreased and nestin+ MSCs no longer express high levels of SCF, VCAM1, Ang-1, and CXCL12. 
Because CXCL12-mediated activation of the CXCR4 receptor on HSCs is a critical niche retention signal, HSCs get mobilized into the periphery via entry 
into the sinusoids. Alternatively, the CXCR4/CXCL12 axis can be inhibited by the clinically used mobilizing agent AMD3100. Additionally, G-CSF stimulates 
the SNS, which contributes to HSC mobilization. CAMS, cell adhesion molecules.426 New players join the HSC niche | Ehninger and Trumpp
MSCs also decreased. Most importantly, the expression of 
CXCL12, which is not produced by macrophages themselves, 
decreased by approximately fivefold in nestin+ MSCs in re-
sponse to G-CSF stimulation (Méndez-Ferrer et al., 2010).
Finally, although HSC mobilization induced by phago-
cyte depletion and via G-CSF stimulation appear to be re-
lated, the latter method is up to 10 times more efficient, 
indicating that G-CSF may also act on a different cell type. 
Along these lines, Chow et al. showed that the SNS is a 
possible  macrophage-independent  G-CSF  target  (Fig.  3). 
SNS fibers are intermingled with nestin+ MSCs and inhibit 
HSC retention by negatively affecting nestin+ MSC activity 
(Katayama et al., 2006; Méndez-Ferrer et al., 2008, 2010). 
The G-CSF–mediated increase in sympathetic tone promotes 
progenitor cell egress, and thus represents a macrophage/
monocyte-independent pathway for G-CSF–mediated mo-
bilization. This provides some explanation as to why G-CSF 
is a much more effective HSC mobilizer than is phagocyte 
depletion (Chow et al., 2011).
The HSC niche unit
These recent studies have significantly increased our under-
standing  of  the  cellular  components  comprising  the  HSC 
niche, and they provide solid data for the involvement of 
nestin+ MSCs, CAR cells, and macrophages. The finding 
that macrophages control both MSCs and OBs, and the ob-
servation  that  MSCs  themselves  generate  OBs,  suggest  a 
complex network of cell–cell interactions forming the three 
dimensional structure of the HSC niche unit. In a fourth di-
mension, this unit is likely to constantly adapt to various in 
vivo challenges to maintain HSCs during steady state and   
under stress. Nevertheless, several questions remain to be an-
swered. First, the relationship between nestin+ MCSs and 
CAR cells needs to be dissected. In addition, although mac-
rophages seem likely to be the major phagocyte player, dif-
ferent methods and only partially overlapping markers have 
been used to identify monocytes and macrophages in the 
marrow and osteomacs at the endosteum. Thus, it will be in-
teresting to see whether several different types of phagocytes 
are niche components or whether only specific subtypes are 
functionally  involved.  The  macrophage-derived  signaling 
molecules that positively influence nestin+ MSCs and OBs 
also remain elusive. Moreover, it remains to be demonstrated 
which cell types directly contact HSCs within the niche and 
which cells produce soluble signaling molecules and thus act 
exclusively in a paracrine manner. There is also significant 
disagreement about the role of OBs, whether (and to what 
level) they express HSC maintenance factors (i.e., Ang-1, 
CXCL12, and SCF), and whether their expression is altered 
in response to G-CSF. Moreover, it is likely that yet other 
cell types may contribute to HSC niche function. For exam-
ple, sinusoidal endothelial cells have been suggested to play a 
role, as they produce angiocrine factors such as Notch li-
gands, which promote HSC self-renewal and regeneration 
after bone marrow injury (Butler et al., 2010; Kobayashi et al., 
2010). Whether sinusoidal endothelial cells also contribute to 
This may settle a long-standing debate about the role of neu-
trophils and neutrophil-derived proteases (neutrophil elastase, 
cathepsin G, and MMP9), which were previously thought   
to be the main drivers of HSC mobilization in response to 
G-CSF (Lévesque et al., 2001; Heissig et al., 2002; Petit et al., 
2002; Christopherson et al., 2003). Although not excluding a 
contribution of neutrophils to G-CSF–induced mobilization, 
Christopher et al. (2011) demonstrate that monocytic cells 
are the key player in this process, at least in mice.
The data by Christopher et al. (2011) suggest that G-CSF–
stimulated monocytes cause the mobilization of HSCs out 
of  their  niche,  but  how  does  this  work?  Mobilization  of 
HSCs from bone marrow niches has been generally attrib-
uted  to  an  overall  decrease  of  bone  marrow  and  serum 
CXCL12 levels, which activates the CXCR4 receptor to 
promote HSC retention—an interaction that is blocked by 
the  mobilizing  compound  AMD3100  (Broxmeyer  et  al., 
2005; De Clercq, 2009). Macrophages have now been iden-
tified as niche components that positively regulate MSCs and 
OBs, which in turn provide HSCs with the necessary extra-
cellular retention factors, including CXCL12. Are these in-
teractions disrupted by G-CSF? Christopher et al. (2011) use 
flow  cytometry  to  show  that  inflammatory  and  resident 
monocytes were reduced up to fivefold 3 d after G-CSF 
treatment. Although it seems unlikely that these two mono-
cyte  populations  also  contain  macrophages,  the  study  by 
Winkler et al. (2010) showed that F4/80+ osteomacs, which 
form a structure similar to a canopy around endosteal OBs, 
were undetectable as early as 2 d after G-CSF stimulation, 
returning 4 d after cessation of G-CSF treatment. Because 
the G-CSF–induced loss of monocytes/macrophages is simi-
lar to the situation in the aforementioned phagocyte deple-
tion models, it is not surprising that G-CSF treatment resulted 
in  the  rapid  depletion  of  endosteal  osteoblastic  activity 
(Winkler et al., 2010). Histomorphometric methods revealed 
a 90% reduction of the bone formation rate, specifically at the 
endosteum. Moreover, the proportion of bone surface lined 
with OBs or newly formed bone matrix was decreased by 
>16-fold  during  mobilization.  This  effect  was  apparent 
within 2 d of G-CSF treatment, preceding the appearance of 
HSCs in the blood (Winkler et al., 2010). As OBs themselves 
do not express the G-CSFR, this effect is indirect and likely 
to be a consequence of G-CSF–mediated depletion of mono-
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G-CSF–mediated mobilization remains to be addressed.   
A recent study suggested that adipocytes, another cell type 
produced by MSCs, have an adverse effect on HSC mainte-
nance (Naveiras et al., 2009). Finally, models suggesting the 
existence of two distinct HSC niches in the bone marrow re-
main to be experimentally confirmed (Fig. 2; Trumpp et al., 
2010). Although such a model would incorporate the cur-
rently available data about the niche components and link it 
to the finding that dormant and actively self-renewing HSCs 
coexist in the marrow, it remains very difficult to identify and   
discriminate these subpopulations in situ, as no definitive 
markers have been reported so far. Future studies will also 
need to further explore the different cocktails of secreted and 
membrane-bound signaling molecules and adhesion recep-
tors expressed by the various niche components that control 
HSC dormancy, self-renewal, lineage-specific priming, and 
survival of HSCs during steady-state hematopoiesis and in 
response to stress.
Concluding remarks
The bone marrow HSC niche has grown up, and it appears 
as complex as one would anticipate considering the various 
functions that HSCs have to fulfill during development,   
homeostasis, and in response to stress situations, such as chemo-
therapy-induced cytopenia or infection with bacteria or viruses. 
Although we now seem to know some, and perhaps the main, 
cellular players, we are far from understanding the three-
dimensional architecture of the HSC niche during homeo-
stasis or how the niche controls HSC function during stress. 
Our increased understanding of normal HSC niches will fos-
ter studies on the leukemic HSC niche, which may reveal 
novel strategies for targeting therapy-resistant leukemic stem 
cells in hematopoietic malignancies.
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